Products

Pixelapse

Visual version control for designers

pixelapse.com Design / UI/UX Design & Prototyping

Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
Unknown
No monthly subscription pricing
Creators
Shravan Reddy
No social account linked+1 more creators
Launched
14y ago
2012-02-09 · Est.

Traffic

Monthly visitsData through Oct 2026

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Show HN (17 pts)Launch

    Colors of your favorite companies

    Oct 9, 2014 · 12y agoLaunch page

  • Launched on Product HuntLaunch

    Visual version control for designers

    Oct 1, 2014 · 12y agoLaunch page

  • Launched on Show HN (78 pts · 23 comments)Launch

    Sync Done Beautifully

    Sep 30, 2014 · 12y agoLaunch page

  • Launched on Show HN (2 pts)Launch

    A Web Based Measurement Tool

    Sep 15, 2014 · 12y agoLaunch page

  • Launched on Show HN (9 pts)Launch

    A Web-Based Color Picker

    Sep 12, 2014 · 12y agoLaunch page

Traffic sources

Oct 2026

Traffic breakdown

No traffic channel or country breakdown data for this website yet.

Search

Domain authority —Domain registered Unknown

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Pricing page not identified yet, or no public pricing listed.

Website snapshots

Indexed 2014-10-01

Key pages

Desktop & mobile archive

Website snapshots pending capture.

Questions & evidence

How much website traffic does Pixelapse get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is Pixelapse and what platforms does it support?
Pixelapse is catalogued under UI/UX Design & Prototyping: Visual version control for designers. Supported platforms: Web.

Related products in this category

Design / UI/UX Design & Prototyping

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.